Federal contract award
75A50120C00171
INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AZ13 — OTHER RESEARCH AND DEVELOPMENT - ADVANCED DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST SHARING |
| Obligations | $48.0M |
| Current contract value | $48.0M |
| Potential contract value / ceiling | $50.1M |
| Start date | Sep 28, 2020 |
| Current end date | Sep 4, 2030 |
| Potential end date | Sep 4, 2030 |
| Latest award activity | Aug 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 14 of 14 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 21, 2026 | P00013 | $9.0M | ADD ADDITIONAL FUNDING TO CLIN 0003 AND EXTEND THE PERIOD OF PERFORMANCE (POP) OF CLIN 0003 |
| May 8, 2026 | P00012 | $3.6M | ADD ADDITIONAL FUNDING TO CLIN 0001, EXTEND THE POP OF PERFORMANCE OF CLIN 0001, UPDATE FAR AND HHS CLAUSES, AND UPDATE THE SOW |
| Jun 18, 2025 | P00011 | $15.3M | INVIRSA - EXERCISE CLIN 0003/OPTION 2; UPDATE THE PERIOD OF PERFORMANCE (POP) FOR CLIN 0001, 0002, 0003 & 0004; UPDATE BUDGETS OF CLIN 0003 & 0004; UPDATE SOW; UPDATE FAR CLAUSES |
| Jul 17, 2024 | P00010 | $2.0M | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Apr 4, 2024 | P00009 | $0 | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Oct 19, 2023 | P00008 | $0 | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Sep 12, 2023 | P00007 | $1.1M | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| May 5, 2023 | P00006 | $0 | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Apr 7, 2023 | P00005 | $0 | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Jan 5, 2023 | P00004 | $0 | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Aug 1, 2022 | P00003 | $0 | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Nov 30, 2021 | P00002 | $0 | EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Dec 10, 2020 | P00001 | $2.5M | INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
| Sep 25, 2020 | 0 | $14.4M | INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. |
Estimated positioning window
Sep 4, 2029 – Mar 4, 2030
45/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 45/100. Available recorded signals: 40 points.
- Contract end 2030-09-04 (1410 days from calculation)
- +5 points
- 2 historical awards in this buyer and category group
- +10 points
- 14 recorded award transactions
- +10 points
- Latest award action: 2026-08-21
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.